Latest News for: mrd

Edit

Phase 3 EMN24 IsKia Study: Quadruplet Isa-KRd Regimen Significantly Improves MRD Negativity in Newly Diagnosed ...

GetNews 22 Apr 2026
Quadruplet Isa-KRd Regimen Significantly Improves MRD Negativity in Newly Diagnosed Multiple Myeloma". The EMN24 IsKia results were based on rigorous NGS MRD testing in all patients who achieved at least a very good partial response.
Edit

FDA Breakthrough for First Viral-Integration MRD Liquid Biopsy in HCC -- New ctDNA Biomarker Class

PR Newswire 21 Apr 2026
HCC remains a blind spot in the MRD landscape — no ctDNA MRD platform has yet pursued BDD for liver cancer, despite HCC being the third leading cause of cancer death globally and having >50% five-year recurrence after resection.
Edit

Integrated DNA Technologies Expands Coralville Manufacturing Footprint to Support Growing Global Demand for MRD Solutions

The Galveston Daily News 20 Apr 2026
CORALVILLE, Iowa--(BUSINESS WIRE)--Apr 20, 2026-- ....
Edit

SAGA Diagnostics to Present New Pathlight™ MRD Data for Ovarian and Metastatic Breast Cancer at ...

The Daily Record - Dunn 18 Apr 2026
Ultrasensitive, structural variant-based ctDNA monitoring reliably tracks therapeutic response and predicts progression ....
Edit

Krypto Trading: X Cashtags knacken 1 Mrd. USD in 2 Tagen!

BitRSS 18 Apr 2026
X verbindet Social Feed und Krypto Trading direkt im Interface. 1 Milliarde US-Dollar Handelsvolumen in nur zwei Tagen zeigen, wie schnell Aufmerksamkeit zu Orderflow werden kann. Wird der Feed damit zum neuen Einstiegspunkt f�r den Markt? ... .
Edit

Ultima Genomics releases groundbreaking TRACERx MRD data showing ppmSeq performance and unveils clinical progress of ...

Lebanon Express 18 Apr 2026
Presenting initial TRACERx MRD data showcasing low single-digit ...
Edit

SAGA Diagnostics to Present New Pathlight™ MRD Data for Ovarian and Metastatic Breast Cancer at AACR 2026

Pharmiweb 18 Apr 2026
David Cescon and Mitchell Elliott at University Health Network (UHN) Canada, a retrospective analysis was conducted for patients with mBC (all subtypes) undergoing standard systemic therapy, utilizing the Pathlight SV-based MRD test.
Edit

Ultima Genomics releases groundbreaking TRACERx MRD data showing ppmSeq performance and unveils clinical progress of whole genome sequencing at inaugural global MRD Symposium at AACR 2026

PR Newswire 17 Apr 2026
Highlighting the program will be initial TRACERx MRD data showcasing the performance of ppmSeq relative to ultrasensitive bespoke panels ... www.ultimagenomics.com/mrd-symposium.
Edit

Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform

The Galveston Daily News 16 Apr 2026
BOSTON--(BUSINESS WIRE)--Apr 16, 2026-- ....
Edit

MRD-Driven Oncology Trials: Regulatory, Clinical and Pharmacology Considerations, Upcoming Webinar Hosted by Xtalks

PR Newswire 16 Apr 2026
In this free webinar, gain a clearer framework for evaluating where minimal residual disease (MRD) fits in an oncology program ... For more information, or to register for this event, visit MRD-Driven Oncology Trials.
Edit

Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform (Foundation Medicine Inc)

Public Technologies 16 Apr 2026
) Pathlight™, a personalized, tumor-informed molecular residual disease (MRD) platform, will expand Foundation Medicine's testing capabilities ... By optimizing for SVs, Pathlight enables ultra-sensitive MRD detection.
Edit

Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma

The Galveston Daily News 13 Apr 2026
AUSTIN, Texas--(BUSINESS WIRE)--Apr 13, 2026-- ....
Edit

Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with ...

The Daily Record - Dunn 13 Apr 2026
41.6% Absolute Difference in the Cema-Cel Arm Over the Observation Arm Exceeded Clinically Meaningful Benchmark Based ....
Edit

Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology, Upcoming Webinar Hosted by Xtalks

PR Newswire 13 Apr 2026
Attendees will learn about the use of molecular residual disease (MRD) as a surrogate endpoint in hematological cancers ... How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology.
Edit

Rec District looks for new leader to take the reigns; MRD won’t renew contract with ...

Montrose Press 09 Apr 2026
With an eye toward future goals, the Montrose Recreation District’s Board of Directors is seeking a new executive director while leaning on current staff during the transition period ... .

Article Search

tools
×
×
×
×